Charge variants characterization and release assay development for co-formulated antibodies as a combination therapy

© 2019, © 2019 The Author(s). Published with license by Taylor & Francis Group, LLC. Combination therapy is a fast-growing strategy to maximize therapeutic benefits to patients. Co-formulation of two or more therapeutic proteins has advantages over the administration of multiple medications, including reduced medication errors and convenience for patients. Characterization of co-formulated biologics can be challenging due to the high degree of similarity in the physicochemical properties of co-formulated proteins, especially at different concentrations of individual components. We present the results of a deamidation study of one monoclonal antibody component (mAb-B) in co-formulated combination antibodies (referred to as COMBO) that contain various ratios of mAb-A and mAb-B. A single deamidation site in the complementarity-determining region of mAb-B was identified as a critical quality attribute (CQA) due to its impact on biological activity. A conventional charge-based method of monitoring mAb-B deamidation presented specificity and robustness challenges, especially when mAb-B was a minor component in the COMBO, making it unsuitable for lot release and stability testing. We developed and qualified a new, quality-control-friendly, single quadrupole Dalton mass detector (QDa)–based method to monitor site-specific deamidation. Our approach can be also used as a multi-attribute method for monitoring other quality attributes in COMBO. This analytical paradigm is applicable to the identification of CQAs in combination therapeutic molecules, and to the subsequent development of a highly specific, highly sensitive, and sufficiently robust method for routine monitoring CQAs for lot release test and during stability studies

Net Work: an interactive artwork designed using an interdisciplinary performative approach

In this paper we outline an interdisciplinary col- laborative approach to problem solving that can be characterised as performative as both the goals and solutions develop over time through an open-ended process of trial-and-error. We describe two projects where this methodology has been successfully applied. We first give an overview of the CELL project where the perfor- mative approach led to a significant change in the way that scientist Neil Theise investigated stem cells. The success of this project directly led to the work which is the main focus of this paper: the design of Net Work, an interactive artwork that consists of a grid of autonomous buoys that emit different coloured light in response to the environment and the state of neighbouring buoys. We describe our performative approach to building the Net Work prototype and outline in detail its control system which is based on Ashby’s homeostat model. The paper concludes with a short discussion of some of the benefits and pitfalls of an interdisciplinary collaborative approach to problem solvin

Progression of Pathogenic Events in Cynomolgus Macaques Infected with Variola Virus

Smallpox, caused by variola virus (VARV), is a devastating human disease that affected millions worldwide until the virus was eradicated in the 1970 s. Subsequent cessation of vaccination has resulted in an immunologically naive human population that would be at risk should VARV be used as an agent of bioterrorism. The development of antivirals and improved vaccines to counter this threat would be facilitated by the development of animal models using authentic VARV. Towards this end, cynomolgus macaques were identified as adequate hosts for VARV, developing ordinary or hemorrhagic smallpox in a dose-dependent fashion. To further refine this model, we performed a serial sampling study on macaques exposed to doses of VARV strain Harper calibrated to induce ordinary or hemorrhagic disease. Several key differences were noted between these models. In the ordinary smallpox model, lymphoid and myeloid hyperplasias were consistently found whereas lymphocytolysis and hematopoietic necrosis developed in hemorrhagic smallpox. Viral antigen accumulation, as assessed immunohistochemically, was mild and transient in the ordinary smallpox model. In contrast, in the hemorrhagic model antigen distribution was widespread and included tissues and cells not involved in the ordinary model. Hemorrhagic smallpox developed only in the presence of secondary bacterial infections – an observation also commonly noted in historical reports of human smallpox. Together, our results support the macaque model as an excellent surrogate for human smallpox in terms of disease onset, acute disease course, and gross and histopathological lesions

Gut Microbiome Dysbiosis in Antibiotic-Treated COVID-19 Patients is Associated with Microbial Translocation and Bacteremia

Although microbial populations in the gut microbiome are associated with COVID-19 severity, a causal impact on patient health has not been established. Here we provide evidence that gut microbiome dysbiosis is associated with translocation of bacteria into the blood during COVID-19, causing life-threatening secondary infections. We first demonstrate SARS-CoV-2 infection induces gut microbiome dysbiosis in mice, which correlated with alterations to Paneth cells and goblet cells, and markers of barrier permeability. Samples collected from 96 COVID-19 patients at two different clinical sites also revealed substantial gut microbiome dysbiosis, including blooms of opportunistic pathogenic bacterial genera known to include antimicrobial-resistant species. Analysis of blood culture results testing for secondary microbial bloodstream infections with paired microbiome data indicates that bacteria may translocate from the gut into the systemic circulation of COVID-19 patients. These results are consistent with a direct role for gut microbiome dysbiosis in enabling dangerous secondary infections during COVID-19

Intoxicação espontânea e experimental por Pterodon emarginatus (Fabaceae Faboideae) em bovinos e experimental em ovinos

Relatam-se mortalidades de bovinos nos Estados de Mato Grosso e Mato Grosso do Sul relacionadas ao consumo de folhas de Pterodon emarginatus. Três surtos ocorreram no período de seca na região Centro-Oeste, após a queda de árvores devido a ventos fortes ou após serem derrubadas para aproveitamento da madeira. Morreram 40 bovinos em três diferentes surtos. A intoxicação foi reproduzida com administração de folhas de P. emarginatus; a dose tóxica mínima foi 20g/kg para ovinos e 6g/kg para bovinos. Os sinais clínicos iniciaram-se entre 24 e 72 horas após o consumo da planta. A evolução clínica da doença letal foi de 12 a 36 horas. Os sinais clínicos se caracterizaram por apatia, depressão, andar a esmo, pressão da cabeça contra objetos. Em dois dos surtos, os bovinos que sobreviveram a fase aguda da doença, desenvolveram fotossensibilização. Os principais achados macroscópicos nos casos espontâneos e experimentais foram no fígado; estes se caracterizaram por hepatomegalia e evidenciação do padrão lobular na superfície capsular e de corte. Notaram-se também hemorragias nas serosas abdominais e torácicas. Microscopicamente observou-se necrose coagulativa hepatocelular, que variou de centrolobular a massiva, por vezes associada à congestão e hemorragia; ocorreu também marcada tumefação e vacuolização de hepatócitos na região periacinar. O diagnóstico foi baseado nos dados epidemiológicos, clínicos, patológicos e na reprodução experimental da intoxicação em bovinos e ovinos. Estes achados caracterizam P. emarginatus como planta hepatotóxica de interesse pecuário na região Centro-Oeste do Brasil

Freshwater Mussels (Bivalvia : Unionidae) in the Verdigris, Neosho, and Spring River Basins of Kansas and Missouri, with Emphasis on Species of Concern

Volume: 14Start Page: 41End Page: 5